Podcast: RNA And Kidneys And Diagnostics RNA, Oh My
Discussing Verici DX’s Differentiated Product Offering
Executive Summary
In this podcast, In Vivo speaks to Sara Barrington, CEO of Verici DX. During the discussion, Barrington outlines the challenges facing patients post-transplant, why current diagnostics are inadequate, and where the overall transplant market is headed, considering the rise of home dialysis and the potential future for xenotransplants.